Panacea Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 22-12-2024
- Paid Up Capital ₹ 2.00 M
as on 22-12-2024
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -17.92%
(FY 2020)
- Profit 56.86%
(FY 2020)
- Ebitda 39.66%
(FY 2020)
- Net Worth -3.39%
(FY 2020)
- Total Assets -3.52%
(FY 2020)
About Panacea Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sumit Jain, Ganesh Kumraj, Sunanda Jain, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74995DL2016PLC300077
- Company No.
300077
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 May 2016
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Panacea Life Sciences?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Jain  | Director | 04-Jul-2016 | Current |
| Ganesh Kumraj | Director | 10-Mar-2022 | Current |
| Sunanda Jain | Director | 27-Jul-2021 | Current |
| Shilpy Jain | Director | 26-Feb-2021 | Current |
| Nipun Jain | Director | 08-Aug-2022 | Current |
| Radhika Jain | Director | 26-Feb-2018 | Current |
Financial Performance of Panacea Life Sciences.
Panacea Life Sciences Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.92% decrease. The company also saw a substantial improvement in profitability, with a 56.86% increase in profit. The company's net worth dipped by a decrease of 3.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panacea Life Sciences?
In 2020, Panacea Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biobridge Healthcare Solutions Private LimitedActive 13 years 5 monthsGanesh Kumraj is a mutual person
Ravinder Heights LimitedActive 5 years 9 monthsSumit Jain, Sunanda Jain and 1 more are mutual person
Nirmala Organic Farms & Resorts Private LimitedActive 15 yearsSumit Jain and Radhika Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Panacea Life Sciences?
Unlock and access historical data on people associated with Panacea Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panacea Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
